Article
Chitotriosidase gene polymorphisms and mutations limit the determination of chitotriosidase expression in sarcoidosis.
Clinica chimica acta; international journal of clinical chemistry - 1 Feb 2021
Csongrádi Alexandra, Altorjay István T, Fülöp Gábor Á, Enyedi Attila, Enyedi Enikő E, Hajnal Péter, Takács István, Tóth Attila, Papp Zoltán, Fagyas Miklós
Abstract excerpt
Serum chitotriosidase (CTO) activity was proposed as a biomarker in sarcoidosis being potentially useful in diagnostics. Nevertheless, a common duplication polymorphism (c.1049_1072dup24, Dup24) of the CTO gene influences CTO activity and thereby compromises its use in sarcoidosis. Here we aimed to substitute CTO activity with CTO concentration to prevent the confounding effect of Dup24. CTO activity,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
